The Global Health Trials Research Group is a collaborative and multidisciplinary team of epidemiologists and social scientists conducting research in the Asia Pacific region. Our expertise is in the design and implementation of clinical trials and observational studies for infectious diseases.
We generate new evidence about the efficacy, implementation, and integration of control strategies, particularly community approaches, for neglected tropical diseases (NTDs) and sexual, reproductive, and maternal health, including sexually transmitted infections (STIs). We work closely with other research groups in the Kirby Institute and with partners in countries in the region, including Fiji, Solomon Islands, Papua New Guinea, Nauru, and Tonga.
We are currently leading a trial together with the Fiji Ministry of Health to investigate the impact of community treatment of STIs on perinatal outcomes in Fiji: a novel, low-cost and feasible solution to reduce the burden of curable STIs and associated adverse health outcomes in high-prevalence settings. We also work on scabies, lymphatic filariasis, and yaws control programs in Fiji and the Solomon Islands, serosurveillance of NTDs in the Western Pacific region, and surveillance of antimicrobial resistance in STIs in Fiji.
